Legal & General Group PLC Intellia Therapeutics, Inc. Transaction History

Legal & General Group PLC

$440 Billion
Q2 2024

A detailed history of Legal & General Group PLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 94,896 shares of NTLA stock, worth $1.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

94,896

Previous 86,557 9.63%

Holding current value

$1.99 Million

Previous $2.38 Million 10.84%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$20.02 - $27.22 $166,946 - $226,987	8,339 Added 9.63%	94,896 $2.12 Million
Q1 2024 May 14, 2024	BUY	$23.82 - $32.8 $138,489 - $190,699	5,814 Added 7.2%	86,557 $2.38 Million
Q4 2023 Feb 15, 2024	BUY	$23.16 - $32.34 $13,803 - $19,274	596 Added 0.74%	80,743 $2.46 Million
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $150,258 - $217,546	4,752 Added 6.3%	80,147 $2.53 Million
Q2 2023 Aug 14, 2023	BUY	$34.58 - $46.03 $44,227 - $58,872	1,279 Added 1.73%	75,395 $3.07 Million
Q1 2023 May 15, 2023	BUY	$33.3 - $44.82 $56,576 - $76,149	1,699 Added 2.35%	74,116 $2.76 Million
Q4 2022 Feb 14, 2023	BUY	$33.21 - $62.69 $129,286 - $244,052	3,893 Added 5.68%	72,417 $2.53 Million
Q3 2022 Nov 14, 2022	SELL	$53.92 - $71.7 $217,405 - $289,094	-4,032 Reduced 5.56%	68,524 $3.83 Million
Q2 2022 Aug 22, 2022	BUY	$38.49 - $76.21 $196,491 - $389,052	5,105 Added 7.57%	72,556 $3.76 Million
Q1 2022 May 16, 2022	BUY	$58.27 - $118.99 $145,849 - $297,831	2,503 Added 3.85%	67,451 $4.9 Million
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $799,026 - $1.1 Million	7,930 Added 13.91%	64,948 $7.68 Million
Q3 2021 Nov 15, 2021	BUY	$132.37 - $176.78 $1.93 Million - $2.58 Million	14,569 Added 34.32%	57,018 $7.65 Million
Q2 2021 Aug 12, 2021	BUY	$60.88 - $161.91 $304,521 - $809,873	5,002 Added 13.36%	42,449 $6.87 Million
Q1 2021 May 17, 2021	SELL	$46.59 - $83.68 $1.3 Million - $2.34 Million	-27,969 Reduced 42.76%	37,447 $3.01 Million
Q4 2020 Feb 12, 2021	SELL	$18.83 - $63.53 $529,744 - $1.79 Million	-28,133 Reduced 30.07%	65,416 $3.56 Million
Q3 2020 Nov 13, 2020	BUY	$17.47 - $24.93 $611,799 - $873,048	35,020 Added 59.83%	93,549 $1.86 Million
Q2 2020 Aug 14, 2020	BUY	$11.14 - $22.87 $423,041 - $868,488	37,975 Added 184.76%	58,529 $1.23 Million
Q1 2020 May 14, 2020	BUY	$9.44 - $15.58 $85,696 - $141,435	9,078 Added 79.1%	20,554 $286,000
Q4 2019 Feb 13, 2020	BUY	$10.43 - $17.67 $13,830 - $23,430	1,326 Added 13.06%	11,476 $168,000
Q3 2019 Nov 13, 2019	BUY	$13.07 - $18.51 $29,316 - $41,517	2,243 Added 28.37%	10,150 $131,000
Q2 2019 Aug 14, 2019	BUY	$13.88 - $18.41 $28,356 - $37,611	2,043 Added 34.84%	7,907 $121,000
Q4 2018 Feb 15, 2019	BUY	$11.39 - $27.13 $4,977 - $11,855	437 Added 8.05%	5,864 $80,000
Q2 2018 Aug 10, 2018	BUY	$20.02 - $30.79 $46,706 - $71,833	2,333 Added 75.4%	5,427 $149,000
Q1 2018 May 17, 2018	SELL	$19.43 - $34.95 $26,910 - $48,405	-1,385 Reduced 30.92%	3,094 $65,000
Q4 2017 Feb 13, 2018	BUY	$17.39 - $31.12 $77,889 - $139,386	4,479	4,479 $87,000

Others Institutions Holding NTLA

# of Institutions

326

Shares Held

88.8M

Call Options Held

673K

Put Options Held

865K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $1.6B
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Intellia Therapeutics, Inc. Transaction History